Trial intelligence / Profile preview

Subcutaneous polyvidone collagen for hand recovery in geriatric RA

NCT06656169Phase 2Completed

Sponsor
Instituto Mexicano del Seguro Social
Start
Jan 2021
Primary completion
Jan 2023
Modality
Hydrogel Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Polyvidone Collagen with Placebo (2 arms). Primary endpoint: Effect of subcutaneous polyvidone collagen treatment on clinical hand recovery at 2 months. Started Jan 2021; status: completed.

02

Drugs

collagen + povidone
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT06656169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06656169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call